threetakesAI NEWS.
THREE PERSPECTIVES.

Research · THREE TAKES BRIEF

AI Fails to Create Scorpion Antivenom in Anthropic Test

Source reported Brief updated

By Three Takes · AI-generated summary and commentary. Our three voices are fictional personas. How our briefs are made

What’s reported

An investment firm's attempt to use Anthropic's Claude to design scorpion antivenom proteins yielded promising binders but not a viable drug, experts told The Verge. The experiment highlighted AI's potential in early discovery but underscored the significant challenges in developing treatments. Based on the linked publisher’s reporting.

Based on reporting from The Verge.

ONE STORY. THREE WAYS TO SEE IT.

The perspectives

AI COMMENTARY

The Optimist

Iris Chen

Fictional AI persona

AI's role in accelerating early-stage drug discovery shows promise, potentially speeding up the identification of therapeutic candidates for complex medical needs.

The Skeptic

Marcus Vale

Fictional AI persona

Anthropic's decision to drop biosecurity guardrails for Citrini's experiment raises concerns about potential misuse of advanced AI models in sensitive scientific research, especially when conducted by non-experts.

The Observer

Alex Morgan

Fictional AI persona

The source confirms that an unreleased Claude model generated protein candidates binding to scorpion toxins but did not produce a functional antivenom. Key unknowns include the proteins' safety, efficacy, and therapeutic viability; experimental validation beyond binding assays would clarify these aspects.

What’s your take?

GO TO THE SOURCE

Read the original reporting

The full context belongs with the original journalism.

KEEP READING

All briefs
Research

Bill Gates believes AI advancements necessitate preparing for approximately two decades of societal disruption. He expressed concerns that current policy and industry responses are insufficient to mitigate risks and ensure beneficial outcomes. Based on the linked publisher’s reporting.

The Verge
Research

Experts argue that in the age of AI, mathematical reasoning and critical thinking are more vital than ever, not less. They emphasize that math underpins understanding AI outputs and is crucial for economic prosperity and problem-solving. Based on the linked publisher’s reporting.

The Guardian
Research

OpenAI has invested in Coherence, a startup developing brain implants to detect cancer. The company aims to use AI to analyze neural signals for early cancer detection and treatment, with plans for human clinical trials. Based on the linked publisher’s reporting.

WIRED

Help improve Three Takes with optional audience measurement. Details